Catatonia in psychiatric illnesses

Dirk M. Dhossche, Lee Elizabeth Wachtel

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Catatonia challenges the validity of modern classification systems by cutting across its proposed boundaries. Contrary to earlier claims that catatonia is restricted to schizophrenia, and soon to be extinct, there is current evidence showing that catatonia is diagnosable in 7 to 17% of acute psychiatric inpatients. A similar proportion of autistic adolescents and adults also meet criteria for catatonia. Sedative treatment and electroconvulsive therapy, the treatments that have historically proven to be effective in catatonia, remain the therapeutic mainstay for catatonia. Evaluation and treatment algorithms that should be helpful when assessing and treating these challenging patients are presented, as well as a GABA-deficit theory of catatonia for guidance of future studies into this syndrome's biochemical correlates. Further studies are needed to optimize the recognition and treatment of catatonia in a wide range of medical and psychiatric patients of different ages.

Original languageEnglish (US)
Title of host publicationThe Medical Basis of Psychiatry: Third Edition
PublisherHumana Press
Pages455-470
Number of pages16
ISBN (Print)9781588299178
DOIs
StatePublished - 2008
Externally publishedYes

Fingerprint

Catatonia
Psychiatry
Therapeutics
Electroconvulsive Therapy
Hypnotics and Sedatives
gamma-Aminobutyric Acid
Inpatients
Schizophrenia

Keywords

  • Autism
  • Benzodiazepines
  • Catatonia
  • Childhood disintegrative disorder
  • Children
  • Delirium
  • Electroconvulsive treatment (ECT)
  • Gamma-aminobutyric acid (GABA)
  • Mood disorder
  • Movement disorders
  • Prader-Willi syndrome
  • Psychomotor abnormalities
  • Psychosis
  • Schizophrenia

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dhossche, D. M., & Wachtel, L. E. (2008). Catatonia in psychiatric illnesses. In The Medical Basis of Psychiatry: Third Edition (pp. 455-470). Humana Press. https://doi.org/10.1007/978-1-59745-252-6_27

Catatonia in psychiatric illnesses. / Dhossche, Dirk M.; Wachtel, Lee Elizabeth.

The Medical Basis of Psychiatry: Third Edition. Humana Press, 2008. p. 455-470.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dhossche, DM & Wachtel, LE 2008, Catatonia in psychiatric illnesses. in The Medical Basis of Psychiatry: Third Edition. Humana Press, pp. 455-470. https://doi.org/10.1007/978-1-59745-252-6_27
Dhossche DM, Wachtel LE. Catatonia in psychiatric illnesses. In The Medical Basis of Psychiatry: Third Edition. Humana Press. 2008. p. 455-470 https://doi.org/10.1007/978-1-59745-252-6_27
Dhossche, Dirk M. ; Wachtel, Lee Elizabeth. / Catatonia in psychiatric illnesses. The Medical Basis of Psychiatry: Third Edition. Humana Press, 2008. pp. 455-470
@inbook{7464d023c1304fa6b21f83cdc1cbc62e,
title = "Catatonia in psychiatric illnesses",
abstract = "Catatonia challenges the validity of modern classification systems by cutting across its proposed boundaries. Contrary to earlier claims that catatonia is restricted to schizophrenia, and soon to be extinct, there is current evidence showing that catatonia is diagnosable in 7 to 17{\%} of acute psychiatric inpatients. A similar proportion of autistic adolescents and adults also meet criteria for catatonia. Sedative treatment and electroconvulsive therapy, the treatments that have historically proven to be effective in catatonia, remain the therapeutic mainstay for catatonia. Evaluation and treatment algorithms that should be helpful when assessing and treating these challenging patients are presented, as well as a GABA-deficit theory of catatonia for guidance of future studies into this syndrome's biochemical correlates. Further studies are needed to optimize the recognition and treatment of catatonia in a wide range of medical and psychiatric patients of different ages.",
keywords = "Autism, Benzodiazepines, Catatonia, Childhood disintegrative disorder, Children, Delirium, Electroconvulsive treatment (ECT), Gamma-aminobutyric acid (GABA), Mood disorder, Movement disorders, Prader-Willi syndrome, Psychomotor abnormalities, Psychosis, Schizophrenia",
author = "Dhossche, {Dirk M.} and Wachtel, {Lee Elizabeth}",
year = "2008",
doi = "10.1007/978-1-59745-252-6_27",
language = "English (US)",
isbn = "9781588299178",
pages = "455--470",
booktitle = "The Medical Basis of Psychiatry: Third Edition",
publisher = "Humana Press",

}

TY - CHAP

T1 - Catatonia in psychiatric illnesses

AU - Dhossche, Dirk M.

AU - Wachtel, Lee Elizabeth

PY - 2008

Y1 - 2008

N2 - Catatonia challenges the validity of modern classification systems by cutting across its proposed boundaries. Contrary to earlier claims that catatonia is restricted to schizophrenia, and soon to be extinct, there is current evidence showing that catatonia is diagnosable in 7 to 17% of acute psychiatric inpatients. A similar proportion of autistic adolescents and adults also meet criteria for catatonia. Sedative treatment and electroconvulsive therapy, the treatments that have historically proven to be effective in catatonia, remain the therapeutic mainstay for catatonia. Evaluation and treatment algorithms that should be helpful when assessing and treating these challenging patients are presented, as well as a GABA-deficit theory of catatonia for guidance of future studies into this syndrome's biochemical correlates. Further studies are needed to optimize the recognition and treatment of catatonia in a wide range of medical and psychiatric patients of different ages.

AB - Catatonia challenges the validity of modern classification systems by cutting across its proposed boundaries. Contrary to earlier claims that catatonia is restricted to schizophrenia, and soon to be extinct, there is current evidence showing that catatonia is diagnosable in 7 to 17% of acute psychiatric inpatients. A similar proportion of autistic adolescents and adults also meet criteria for catatonia. Sedative treatment and electroconvulsive therapy, the treatments that have historically proven to be effective in catatonia, remain the therapeutic mainstay for catatonia. Evaluation and treatment algorithms that should be helpful when assessing and treating these challenging patients are presented, as well as a GABA-deficit theory of catatonia for guidance of future studies into this syndrome's biochemical correlates. Further studies are needed to optimize the recognition and treatment of catatonia in a wide range of medical and psychiatric patients of different ages.

KW - Autism

KW - Benzodiazepines

KW - Catatonia

KW - Childhood disintegrative disorder

KW - Children

KW - Delirium

KW - Electroconvulsive treatment (ECT)

KW - Gamma-aminobutyric acid (GABA)

KW - Mood disorder

KW - Movement disorders

KW - Prader-Willi syndrome

KW - Psychomotor abnormalities

KW - Psychosis

KW - Schizophrenia

UR - http://www.scopus.com/inward/record.url?scp=84892362524&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892362524&partnerID=8YFLogxK

U2 - 10.1007/978-1-59745-252-6_27

DO - 10.1007/978-1-59745-252-6_27

M3 - Chapter

AN - SCOPUS:84892362524

SN - 9781588299178

SP - 455

EP - 470

BT - The Medical Basis of Psychiatry: Third Edition

PB - Humana Press

ER -